Metoprolol
Acute coronary syndrome is a group of conditions that can be classified based on clinical and diagnostic findings. The three conditions comprising the group of conditions (unstable angina, non-ST elevation myocardial infarction,and ST elevation myocardial infarction) present with similar signs and symptoms of chest pain, dyspnea, and diaphoresis, among others. . Medical management also includes nitrates, beta-blockers, such as metoprolol, angiotensin-converting enzyme (ACE) inhibitors, such as lisinopril, oxygen, morphine, anticoagulant therapy (heparin), antiplatelet therapy (aspirin), and HMG-CoA reductase inhibitors (atorvastatin). Supplemental oxygen should be given to maintain arterial oxygen saturation above 90%. It is not indicated in normoxic patients as it can cause vasoconstriction of the coronary arteries. Morphine has been associated with high risk of death and should be administered only for severe, persistent chest pain that is not relieved by other treatment strategies. Beta-blockers and ACE inhibitors have been shown to have the most significant impact on long-term recovery as they prevent permanent remodeling of the cardiac tissue following infarct. Aspirin (A), although part of the treatment protocol for acute coronary syndrome, serves as antiplatelet therapy during acute ischemia and does not have as significant long-term benefits compared to beta-blocker therapy. Similarly, nitroglycerin (C) is used in treating acute coronary syndrome to relieve pain associated with ischemia but does not have long-term effects. Nitrates should be used with caution in patients with right ventricular infarction or severe aortic stenosis as it can cause hypotension and hemodynamic decompensation. All patients should be started on high-intensity statin therapy (atorvastatin or rosuvastatin) within 24 hours of acute myocardial infarction to decrease further coronary artery disease events. Simvastatin (D) is a moderate intensity statin and is therefore not a first-line lipid-lowering agent following myocardial infarction. Atorvastatin is a high-intensity statin that should be prescribed to all patients after acute coronary syndrome. Permanent pacemaker placement
Atrioventricular block is a cardiac dysrhythmia defined as a delay or interruption in the electrical impulses from the atria to the ventricles. Also termed heart block, this delay is categorized as first-degree when the PR interval exceeds 200 milliseconds with all atrial impulses conducted to the ventricles. Second-degree heart block presents with intermittently blocked beats while third-degree heart block (complete heart block) results in no atrial impulses being transmitted to the ventricles. Second-degree heart block can be divided into Mobitz type I (Wenckebach), in which the PR interval progressively lengthens prior to a blocked beat, and Mobitz type II, which presents with intermittently nonconducted atrial beats not preceded by a lengthening PR interval. Mobitz type II atrioventricular block has pathologic and iatrogenic etiologies including myocardial ischemia, cardiomyopathy, myocarditis, hyperkalemia, postcardiac surgery, and postcatheter ablation, among others. Abstain from alcohol consumption
Heart failure describes ventricular dysfunction resulting from diastolic filling deficits, poor systolic contractility, or both. Common causes of heart failure include hypertension, obesity, smoking, excessive alcohol consumption, congenital or valvular heart disease,ischemic heart disease, rheumatic heart disease, pregnancy, and chest radiation. Monitor weight on home scale weekly (B) is not often enough. Minor changes in weight can signify decompensated heart failure, which calls for hospitalization or medication change. Therefore, patients with any class of heart failure should be encouraged to measure their weight on a home scale daily and report any increase of 2 lbs or more to their health care provider. Reduce fluid intake to 1.5 L per day (C) is not recommended. In fact, fluid restriction of any type in heart failure patients is not advised, unless the patient has symptomatic hyponatremia or refractory class IV heart failure. The patient in the above vignette had a normal serum sodium (as evidenced by the normal complete metabolic panel) and would fall in the class III heart failure category. Reduce sodium intake to 1.5 g per day (D) is too stringent and not necessary. Sodium reduction to 3 g or less per day is much more manageable for the patient and is recommended by the American College of Cardiologists and American Heart Association, according to their 2017 heart failure guidelines. Radiofrequency ablation
Diagnosis of atrial flutter is with electrocardiogram, where a regular, rapid atrial rate will appear as a sawtooth pattern and QRS complexes will be equally spaced and rapid. Treatment of atrial flutter must address the rapid rate, work to return the patient to normal sinus rhythm, prevent systemic emboli, and prevent recurrence of the dysrhythmia. Beta-blockers or calcium channel blockers are often given for rate control, and heparin is initiated for prevention of embolization. Return to normal sinus rhythm can be accomplished with antidysrhythmic agents, cardioversion, or radiofrequency ablation of accessory pathways. The latter is the preferred method because it provides definitive treatment and lower likelihood of recurrence. Patients who are hemodynamically unstable should undergo urgent cardioversion. Amiodarone (A) is an antidysrhythmic agent that can slow the atrial flutter rate and conduction through the atrioventricular node. However, amiodarone carries the risk of leading to a 1:1 atrioventricular conduction rate, which can increase the heart rate in a patient with atrial flutter. This is because the atrioventricular conduction rate is normally 2:1 in atrial flutter. Patients who are hemodynamically stable may be candidates for oral antidysrhythmic agents and anticoagulants while they wait for spontaneous return of normal sinus rhythm, although this is not guaranteed to occur. 7th Edition•ISBN: 9780323527361Julie S Snyder, Mariann M Harding2,512 solutions
7th Edition•ISBN: 9780323402118Gary A. Thibodeau, Kevin T. Patton1,505 solutions
7th Edition•ISBN: 9780323087896 (1 more)Julie S Snyder, Linda Lilley, Shelly Collins388 solutions
4th Edition•ISBN: 9781264154371David M Allan, Rachel Basco404 solutions